About us…
Founded in 2024, Novo Silico is a privately owned and funded venture, headquartered in suburban Zurich, Switzerland. Beyond scientific prowess and technological skill, our shared core assets are:
- Enthusiasm for the design, visualization and optimization of new, groundbreaking digital solutions for molecular and cellular biochemistry and polymer engineering.
- Ambition to resolve global challenges around climate change, pollution, cancer, cardiovascular and neurodegenerative diseases.
- Drive to deliver comprehensive and validated digital project results to clients and partners on time and on budget, with highest quality standards.
Growing Team
Our small but growing team is aggregating decades of experience in the life science, material science, power and petrochemical industries. Our consolidated functional expertise is focusing on analytical, predictive and generative AI, covering the entire digital product life cycle, from early opportunity exploration to development, productization and successful commercial management. This includes documentation and protection of new digital IP.
Strategic Investors
We are open to strategic private and institutional investors, contributing funding, resources, opportunities and/or valuable contacts in our target markets. In return, we may offer equity shares and privileged access to know-how, hard- and software and protected IP.
Career Opportunities
We are hiring! Join us now!
- We appreciate self-initiated applications and proposals for roles in business development, in relevant industrial and regional segments. We particularly encourage such applications on a commission basis.
- For other managerial, scientific and technical positions, we will publish and post profiles in due course. Please re-visit this site periodically.